[ European Foundation For the Study of Diabetes (EFSD) and Novo Nordisk I Research funding on diabetes ]

Thumbnail

Event details

Date 01.02.2021
Category Call for proposal

The European Foundation for the Study of Diabetes (EFSD) and the healthcare company Novo Nordisk call for applications for the A/S Programme for Diabetes Research in Europe.  

Applications from all fields of diabetes research including both basic and clinical research are accepted.

Who can apply:

  • Applicants based at non-profit institutions in the EU and Associated Countries.
  • The PI and Co-PIs must be normally employed at a non-profit institution and the study must be performed at their place of work.
  • Applicants to all EFSD programmes must be paid-up members of EASD.
  • Only one EFSD award per PI or Co-PI at a time.
  • There can be more than one EFSD award per lab, but for separate projects.

Funding:
  • Max. EUR 100’000 for basic research and/or clinical research.
  • The budget must be prepared in EUR and it must mention the exchange rate.
  • Please mention all funding requested and obtained from other sources.
  • Eligible costs: personnel, 10% OH, equipment, supplies, other project-related costs.

Duration: One year or longer

Deadline: 1 February 2021 at 12:00 (CET)
Decision: May 2021

For further information, please have a look at the call webpage (incl. evaluation criteria), the online application form) and past grantees.
 

Practical information

  • General public
  • Free

Contact

Tags

research funding

Event broadcasted in

Share